RRM2 and hepatocellular carcinoma: Among others, RRM2 has been reported as a member of the ferric iron-binding ferritin superfamily and that RRM2 engaged in the iron metabolism in hepatocellular carcinoma (Key et al., 2020; Shen et al., 2021).